Insider Trading & Ownership - Avalo Therapeutics Inc. (AVTX)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Avalo Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-06-15
Purchase		 2023-06-20
4:04 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 8,160 $3.8779 $31,644 1,608,000
(Indirect
Direct)		 View
2023-06-12
Purchase		 2023-06-14
4:14 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 16,899 $3.7653 $63,629 1,599,840
(Indirect
Direct)		 View
2023-06-09
Purchase		 2023-06-13
4:41 pm		 Avalo Therapeutics Inc. AVTX Sullivan Christopher Ryan
Chief Financial Officer		 511 $3.42 $1,748 1,262
(Direct)		 View
2023-06-09
Purchase		 2023-06-13
4:39 pm		 Avalo Therapeutics Inc. AVTX NEIL GARRY ARTHUR
CEO and Chairman of the Board		 4,000 $3.42 $13,680 13,220
(Direct)		 View
2023-06-07
Purchase		 2023-06-09
4:24 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 14,426 $3.9124 $56,440 1,582,941
(Indirect
Direct)		 View
2023-05-31
Purchase		 2023-06-02
4:22 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 844 $2.87 $2,422 1,568,515
(Indirect
Direct)		 View
2023-05-25
Purchase		 2023-05-30
4:27 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 2,671 $2.7944 $7,464 1,567,671
(Indirect
Direct)		 View
2023-05-24
Purchase		 2023-05-24
4:15 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 9,000 $2.9796 $26,816 1,565,000
(Indirect
Direct)		 View
2023-05-18
Purchase		 2023-05-22
4:30 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 26,621 $3.3572 $89,372 1,556,000
(Indirect
Direct)		 View
2023-05-12
Purchase		 2023-05-16
5:23 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 4,379 $2.5135 $11,007 1,529,379
(Indirect
Direct)		 View
2023-05-04
Purchase		 2023-05-08
4:10 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 25,000 $2.7746 $69,365 1,525,000
(Indirect
Direct)		 View
2023-04-25
Purchase		 2023-04-27
4:07 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 7,500 $2.9898 $22,423 1,500,000
(Indirect
Direct)		 View
2023-04-20
Purchase		 2023-04-24
4:32 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 17,500 $3.0669 $53,672 1,492,500
(Indirect
Direct)		 View
2023-04-17
Purchase		 2023-04-18
4:08 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 25,000 $2.955 $73,874 1,475,000
(Indirect
Direct)		 View
2023-04-10
Purchase		 2023-04-11
4:51 pm		 Avalo Therapeutics Inc. AVTX Caissa Capital Management ltd.
10% Owner		 56,329 $2.5301 $142,516 1,450,000
(Indirect
Direct)		 View
2023-02-07
Purchase		 2023-02-09
4:32 pm		 Avalo Therapeutics Inc. AVTX ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner		 450,000 $0 $0 4,899,370
(Indirect
Direct)		 View
2022-12-09
Purchase		 2022-12-12
4:22 pm		 Avalo Therapeutics Inc. AVTX NEIL GARRY ARTHUR
CEO and Chairman of the Board		 2,083 $4.42 $9,207 9,220
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2023-05-15
Option Award		 2023-05-17
07:44 am		 2024-05-15
2033-05-15		 Avalo Therapeutics Inc. AVTX Sullivan Christopher Ryan
Chief Financial Officer		 40,000 $0 40,000
(Direct)		 View
2023-05-15
Option Award		 2023-05-17
07:43 am		 2024-05-15
2033-05-15		 Avalo Therapeutics Inc. AVTX NEIL GARRY ARTHUR
CEO and Chairman of the Board		 100,000 $0 100,000
(Direct)		 View
2023-03-31
Option Award		 2023-04-04
4:09 pm		 2023-03-31
2033-03-31		 Avalo Therapeutics Inc. AVTX Almenoff June Sherie
Director		 1,167 $0 1,167
(Direct)		 View
2023-03-31
Option Award		 2023-04-04
4:07 pm		 2023-03-31
2033-03-31		 Avalo Therapeutics Inc. AVTX Persson Magnus
Director		 7,222 $0 7,222
(Direct)		 View
2023-02-13
Option Award		 2023-02-15
4:19 pm		 N/A
2033-02-13		 Avalo Therapeutics Inc. AVTX Sullivan Christopher Ryan
Chief Financial Officer		 40,000 $0 40,000
(Direct)		 View
2023-02-13
Option Award		 2023-02-15
4:16 pm		 N/A
2033-02-13		 Avalo Therapeutics Inc. AVTX NEIL GARRY ARTHUR
CEO and Chairman of the Board		 100,000 $0 100,000
(Direct)		 View
2023-02-03
Acquisition		 2023-02-09
4:32 pm		 N/A
N/A		 Avalo Therapeutics Inc. AVTX ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner		 334 $3.95 4,899,370
(Indirect)		 View
2022-12-30
Option Award		 2023-01-03
4:13 pm		 2022-12-30
2032-12-30		 Avalo Therapeutics Inc. AVTX Persson Magnus
Director		 2,536 $0 2,536
(Direct)		 View
2022-12-30
Option Award		 2023-01-03
4:11 pm		 2022-12-30
2032-12-30		 Avalo Therapeutics Inc. AVTX Almenoff June Sherie
Director		 410 $0 410
(Direct)		 View
2022-10-05
Option Award		 2022-10-07
4:03 pm		 2023-10-05
2032-10-05		 Avalo Therapeutics Inc. AVTX NEIL GARRY ARTHUR
CEO and Chairman of the Board		 75,000 $0 75,000
(Direct)		 View
2022-10-05
Option Award		 2022-10-07
4:01 pm		 2023-10-05
2032-10-05		 Avalo Therapeutics Inc. AVTX Sullivan Christopher Ryan
Chief Financial Officer		 25,000 $0 25,000
(Direct)		 View
2022-09-30
Option Award		 2022-10-03
4:28 pm		 2022-09-30
2032-09-30		 Avalo Therapeutics Inc. AVTX Almenoff June Sherie
Director		 605 $0 605
(Direct)		 View
2022-09-30
Option Award		 2022-10-03
4:25 pm		 2022-09-30
2032-09-30		 Avalo Therapeutics Inc. AVTX KAPLAN GILLA
Director		 3,080 $0 3,080
(Direct)		 View
2022-09-30
Option Award		 2022-10-03
4:21 pm		 2022-09-30
2032-09-30		 Avalo Therapeutics Inc. AVTX Persson Magnus
Director		 3,747 $0 3,747
(Direct)		 View
2022-06-30
Option Award		 2022-07-05
5:34 pm		 2022-06-30
2032-06-30		 Avalo Therapeutics Inc. AVTX Persson Magnus
Director		 26,837 $0 26,837
(Direct)		 View
2022-06-30
Option Award		 2022-07-01
4:07 pm		 2022-06-30
2032-06-30		 Avalo Therapeutics Inc. AVTX KAPLAN GILLA
Director		 44,115 $0 44,115
(Direct)		 View
2022-06-30
Option Award		 2022-07-01
4:00 pm		 2022-06-30
2032-06-30		 Avalo Therapeutics Inc. AVTX Almenoff June Sherie
Director		 4,338 $0 4,338
(Direct)		 View
2022-06-14
Option Award		 2022-06-16
4:01 pm		 2023-06-14
2032-06-14		 Avalo Therapeutics Inc. AVTX Persson Magnus
Director		 40,000 $0 40,000
(Direct)		 View
2022-06-14
Option Award		 2022-06-15
4:30 pm		 2023-06-14
2032-06-14		 Avalo Therapeutics Inc. AVTX KAPLAN GILLA
Director		 40,000 $0 40,000
(Direct)		 View
2022-06-14
Option Award		 2022-06-15
4:23 pm		 2023-06-14
2032-06-14		 Avalo Therapeutics Inc. AVTX Chan Mitchell
Director		 40,000 $0 40,000
(Direct)		 View
2022-06-14
Option Award		 2022-06-15
4:15 pm		 2023-06-14
2032-06-14		 Avalo Therapeutics Inc. AVTX Almenoff June Sherie
Director		 40,000 $0 40,000
(Direct)		 View
2022-03-31
Option Award		 2022-04-04
6:25 pm		 2022-03-31
2032-03-31		 Avalo Therapeutics Inc. AVTX Persson Magnus
Director		 18,468 $0 18,468
(Direct)		 View
2022-03-31
Option Award		 2022-04-04
6:06 pm		 2022-03-31
2032-03-31		 Avalo Therapeutics Inc. AVTX Miller Joseph M
Director		 20,239 $0 20,239
(Direct)		 View
2022-03-31
Option Award		 2022-04-04
5:37 pm		 2022-03-31
2032-03-31		 Avalo Therapeutics Inc. AVTX KAPLAN GILLA
Director		 30,359 $0 30,359
(Direct)		 View
Goto Prev, 0, 1, 2, 3, 4, Next